title: Enlarging ulcers in the mouth and on the back. Granulomatosis with polyangiitis.
authors: *Department of Dermatology, Division of General Dermatology, Medical University of Graz, Graz, Austria †Department of Specialistic Medicine, Unit of Pneumology, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy ‡Unit of Social Dermatology, National Reference Center for Hansen's Disease, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy §Department of Pathology, Galliera Hospital, Genoa, Italy.
authors: Cesare
authors: C
authors: Massone
authors: Raffaella
authors: R
authors: Felletti
authors: Salvatore
authors: S
authors: Noto
authors: David
authors: D
authors: Pelucco
authors: Roberto
authors: R
authors: Bandelloni
authors: Gianfranco
authors: G
authors: Barabino
mesh_terms: D001415:Back; D001706:Biopsy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019226:Oral Ulcer / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D011237:Predictive Value of Tests; D011239:Prednisolone / Q000627:therapeutic use; D012307:Risk Factors; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology*; D012883:Skin Ulcer / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone